Skip to main content
SpringerLink
Log in

Cardiovascular and Respiratory Systems

  • Chapter
The Growth Hormone/Insulin-Like Growth Factor Axis During Development

Part of the book series: Advances in Experimental Medicine and Biology ((volume 567))

  • 1230 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. P.A. Doevendans, M.J. Daemen, E.D. de Muinck and J.F. Smits, Cardiovascular phenotyping in mice. Cardiovasc Res, 39, 34–49 (1998).

    Article  PubMed  CAS  Google Scholar 

  2. J. D’Armiento, Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction. Trends Cardiovasc Med, 12, 97–101 (2002).

    Google Scholar 

  3. G.T. Copper, Basic determinants of myocardial hypertrophy: a review of molecular mechanisms. Annu Rev Med, 48, 13–23 (1997).

    Article  Google Scholar 

  4. Frey N, McKinsey TA, Olson EN. Decoding calcium signals involved in cardiac growth and function. Nat Med; 6:1221–1227 (2000).

    Article  CAS  Google Scholar 

  5. K. Kjeldsen, A. Norgaard and M. Gheorghiade, Myocardial Na+,K+-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure. Cardiovasc Res, 55, 710–713 (2002).

    Article  PubMed  CAS  Google Scholar 

  6. K.R. Sipido, P.G. Volders, M.A. Vos and F. Verdonck, Altered Na+/Ca2+ exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc Res, 53, 782–805 (2002).

    Article  PubMed  CAS  Google Scholar 

  7. Z. Xie, P. Kometiani, J. Liu, J. Li, J.I. Shapiro and A. Askari, Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem, 274, 19323–19328 (1999).

    Article  PubMed  CAS  Google Scholar 

  8. A.C. Guyton, Textbook of medical physiology, Seventh ed. W B Saunders company, Philadelphia, PA, USA (1986).

    Google Scholar 

  9. Behrendt D, Ganz P. Endothelial function. From vascular biology to clinical applications. Am J Cardiol, 90, 40L–48L (2002).

    Article  PubMed  CAS  Google Scholar 

  10. Luscher TF, Barton M. Biology of the endothelium. Clin Cardiol, 20, II-3–10 (1997).

    Google Scholar 

  11. M. Lavallee, M. Takamura, R. Parent and E. Thorin, Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail Rev, 6, 265–76 (2001).

    Article  PubMed  CAS  Google Scholar 

  12. E.B. Braunwald and J. Ross Jr, Control of cardiac performance. In: Handbook of Physiology. American Physiological Society, Bethesda, pp 533–580 (1979).

    Google Scholar 

  13. L Sacca, A Cittadini, S. Fazio Growth hormone and the heart. Endocr Rev, 15, 555–573 (1994).

    Article  PubMed  CAS  Google Scholar 

  14. J Ren, WK Samson, JR. Sowers Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol, 31, 2049–2061 (1999).

    Article  PubMed  CAS  Google Scholar 

  15. Z. Nagy, A. Busjahn, S. Bahring, H.D. Faulhaber, H.D. Gohlke, H. Knoblauch, M. Rosenthal, B. Muller-Myhsok, H. Schuster and F.C. Luft, Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man. J Am Soc Nephrol, 10, 1709–16 (1999).

    PubMed  CAS  Google Scholar 

  16. J. Isgaard, A. Nilsson, K. Vikman and O.G. Isaksson Growth hormone regulates the level of insulin-like growth factor-I mRN,A in rat skeletal muscle. J Endocrinol, 120, 107–112 (1989).

    PubMed  CAS  Google Scholar 

  17. A.J. D’Ercole, A.D. Stiles and L.E. Underwood, Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA, 81, 935–9399 (1984).

    Google Scholar 

  18. P. Delafontaine, K.E. Bernstein and R.W. Alexander, Insulin-like growth factor I gene expression in vascular cells. Hypertension, 17, 693–699 (1991).

    PubMed  CAS  Google Scholar 

  19. L.S. Mathews, B. Enberg, G. Norstedt, Regulation of rat growth hormone receptor gene expression. J Biol Chem, 264, 9905–9910 (1989).

    PubMed  CAS  Google Scholar 

  20. J. Isgaard, H. Wåhlander, M.A. Adams and P. Friberg, Increased expression of growth hormone receptor mRNA and insulin-like growth factor-I mRNA in volume-overloaded hearts. Hypertension, 23, 884–888 (1994).

    PubMed  CAS  Google Scholar 

  21. A. Wickman, P. Friberg, M.A. Adams, G.L. Matejka, C. Brantsing, G. Guron, J. Isgaard, Induction of growth hormone receptor and insulin-like growth factor-I mRNA in aorta and caval vein during hemodynamic challenge. Hypertension, 29, 123–130 (1997).

    PubMed  CAS  Google Scholar 

  22. H.P. Guler, J. Zapf, E. Scheiwiller, E.R. Froesch, Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA, 85, 4889–4893 (1988).

    Article  PubMed  CAS  Google Scholar 

  23. A. Wickman, J. Isgaard, M.A. Adams, P. Friberg, Inhibition of nitric oxide in rats. Regulation of cardiovascular structure and expression of insulin-like growth factor I and its receptor messenger RNA. J Hypertens, 15, 751–759 (1997).

    Article  PubMed  CAS  Google Scholar 

  24. G. Pete, Y. Hu, M. Walsh, J. Sowers and J.C. Dunbar, Insulin-like growth factor-I decreases mean blood pressure and selectively increases regional blood flow in normal rats. Proc Soc Exp Biol Med, 213, 187–192 (1996).

    PubMed  CAS  Google Scholar 

  25. M.F. Walsh, M. Barazi, G. Pete, R. Muniyappa, J.C. Dunbar and J.R. Sowers, Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology, 137, 1798–1803 (1996).

    Article  PubMed  CAS  Google Scholar 

  26. M.Y. Donath, R. Jenni, H.P. Brunner, M. Anrig, S. Kohli, Y. Glatz and E.R. Froesch, Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans. J Clin Endocrinol Metab, 81, 4089–4094 (1996).

    Article  PubMed  CAS  Google Scholar 

  27. M.Y. Donath, G. Sutsch, X.W. Yan, B. Piva, H.P. Brunner, Y. Glatz, J. Zapf, F. Follath, E.R. Froesch and W. Kiowski, Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure. J Clin Endocrinol Metab, 83, 3177–3183 (1998).

    Article  PubMed  CAS  Google Scholar 

  28. F. Manelli, M. Volterrani, R. Lorusso, G. Romanelli and A. Giustina. Acute growth hormone effects in human subjects with heart failure. In: Growth hormone and the heart, F. Manelli (ed) Kluwer Academic Publishers, Boston, pp 87–96 (2001).

    Google Scholar 

  29. R. Napoli, V. Guardasole, V. Angelini, F. D’Amico, E. Zarra, M. Matarazzo and L. Saccá, Acute effects of growth hormone on vascular function in human subjects. J Clin Endocrinol Metab, 88, 2817–2820 (2003).

    Article  PubMed  CAS  Google Scholar 

  30. H. Tsukahara, D.V. Gordienko, B. Tonshoff, M.C. Gelato, and M.S. Goligorsky Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int, 45, 598–604 (1994).

    PubMed  CAS  Google Scholar 

  31. R. Muniyappa, M.F. Walsh, J.S. Rangi, R.M. Zayas, P.R. Standley, J.L. Ram and J.R. Sowers, Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production. Life Sci, 61, 925–931 (1997).

    Article  PubMed  CAS  Google Scholar 

  32. J. Haylor, I. Singh and A.M. el Nahas, Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int, 39, 333–335 (1991).

    PubMed  CAS  Google Scholar 

  33. D.A. Fryburg, NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF-I: possible role of nitric oxide in muscle protein synthesis. J Clin Invest, 97, 1319–1328 (1996).

    PubMed  CAS  Google Scholar 

  34. C.L. Oltman, N.L. Kane, D.D. Gutterman, R.S. Bar and K.C. Dellsperger, Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size. Am J Physiol Endocrinol Metab, 279, E176–181 (2000).

    PubMed  CAS  Google Scholar 

  35. R. Hirschberg and J.D. Kopple, Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest, 83, 326–330 (1989).

    PubMed  CAS  Google Scholar 

  36. D. Hasdai, R.A. Rizza, D.R. Holmes Jr., D.M. Richardson, P. Cohen and A. Lerman, Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. Hypertension, 32, 228–34 (1998).

    PubMed  CAS  Google Scholar 

  37. P.R. Standley, F. Zhang, R.M. Zayas, R. Muniyappa, M.F. Walsh, E. Cragoe and J.R. Sowers, IGF-I regulation of Na+/K+-ATPase in rat arterial smooth muscle. Am J Physiol, 273, E113–121 (1997).

    PubMed  CAS  Google Scholar 

  38. G. Lembo, H.A. Rockman, J.J. Hunter, H. Steinmetz, W.J. Koch, L. Ma, M.P. Prinz, J. Ross Jr., K.R. Chien and L. Powell-Braxton, Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J Clin Invest, 98,:2648–2655 (1996).

    PubMed  CAS  Google Scholar 

  39. Å. Tivesten, E. Bollano, I. Andersson, S. Fitzgerald, K. Caidahl, K. Sjögren, J. Skøtt, J-L. Liu, D. LeRoith, R. Mobini, O.G.P. Isaksson, J-O. Jansson, C. Ohlsson, G. Bergstrom and J. Isgaard, Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in nice. Endocrinology, 143, 4235–4242 (2002).

    Article  PubMed  CAS  Google Scholar 

  40. S.J. Fuller, J.R. Mynett and P.H. Sugden Stimulation of cardiac protein synthesis by insulin-like growth factors. Biochem J, 282, 85–90 (1992).

    PubMed  CAS  Google Scholar 

  41. M.Y. Donath, J. Zapf, M. Eppenberger-Eberhardt, E.R. Froesch and H.M. Eppenberger Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc Natl Acad Sci USA, 91, 1686–1690 (1994).

    Article  PubMed  CAS  Google Scholar 

  42. H. Ito, M. Hiroe, Y. Hirata, M. Tsujino, S. Adachi, M. Shichiri, A. Koike, A. Nogami and F. Marumo Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation, 87, 1715–1721 (1993).

    PubMed  CAS  Google Scholar 

  43. C. Lu, G. Schwartzbauer, M.A. Sperling, S.U. Devaskar, S. Thamotharan, P.D. Robbins, C.F. McTiernan, J.L. Liu, J. Jiang, S.J. Frank and R.K. Menon. Demonstration of direct effects of growth hormone on neonatal cardiomyocytes. J Biol Chem, 276, 22892–900 (2001).

    Article  PubMed  CAS  Google Scholar 

  44. M.Y. Donath, M.A. Gosteli-Peter, C. Hauri, E.R. Froesch and J. Zapf, Insulin-like growth factor-I stimulates myofibrillar genes and modulates atrial natriuretic factor mRNA in rat heart. Eur J Endocrinol, 137, 309–315 (1997).

    Article  PubMed  CAS  Google Scholar 

  45. A. Musaro, K.J. McCullagh, F.J. Naya, E.N. Olson, N. Rosenthal, IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature, 400, 581–585 (1999).

    Article  PubMed  CAS  Google Scholar 

  46. E.E. Creemers, J.P. Cleutjens, J.F. Smits and M.J. Daemen, Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res, 89, 201–210 (2001).

    PubMed  CAS  Google Scholar 

  47. RP Butt, GJ Laurent and JE Bishop, Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur J Cell Biol, 68, 330–335 (1995).

    PubMed  CAS  Google Scholar 

  48. A. Bruel and H. Oxlund, Biosynthetic growth hormone increases the collagen deposition rate in rat aorta and heart. Eur J Endocrinol, 132, 195–199 (1995).

    Article  PubMed  CAS  Google Scholar 

  49. P. Schnabel, F. Mies, T. Nohr, M. Geisler and M. Bohm, Differential regulation of phospholipase C-beta isozymes in cardiomyocyte hypertrophy. Biochem Biophys Res Commun, 275, 1–6 (2000).

    Article  PubMed  CAS  Google Scholar 

  50. A. Cittadini, H. Stromer, S.E. Katz, R. Clark, A.C. Moses, J.P. Morgan and P.S. Douglas, Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation, 93, 800–809 (1996).

    PubMed  CAS  Google Scholar 

  51. A. Bruel, H. Oxlund and J.R. Nyengaard, Growth hormone increases the total number of myocyte nuclei in the left ventricle of adult rats. Growth Horm IGF Res, 12, 106–115 (2002).

    Article  PubMed  CAS  Google Scholar 

  52. J. Kajstura, W. Cheng, R. Sarangarajan, P. Li, B. Li, J.A. Nitahara, S. Chapnick, K. Reiss, G. Olivetti and P. Anversa, Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. AmJPhysiol, 271, H1215–1228 (1996).

    CAS  Google Scholar 

  53. U. Vetter, C. Kupferschmid, D. Lang and S. Pentz, Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocytes in vitro. Basic Res Cardiol, 83, 647–654 (1988).

    Article  PubMed  CAS  Google Scholar 

  54. N.S. Freestone, S. Ribaric and W.T. Mason, The effect of insulin-like growth factor-1 on adult rat cardiac contractility. Mol Cell Biochem, 163–164, 223–229 (1996).

    Google Scholar 

  55. A. Cittadini, Y. Ishiguro, H. Stromer, M. Spindler, A.C. Moses, R. Clark, P.S. Douglas, J.S. Ingwall and J.P. Morgan, Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles. Circ Res, 83, 50–59 (1998).

    PubMed  CAS  Google Scholar 

  56. H. Stromer, A. Cittadini, P.S. Douglas, J.P. Morgan, Exogenously administered growth hormone and insulin-like growth factor-I alter intracellular Ca2+ handling and enhance cardiac performance. In vitro evaluation in the isolated isovolumic buffer-perfused rat heart. Circ Res, 79, 227–236 (1996).

    PubMed  CAS  Google Scholar 

  57. M. Tajima, E.O. Weinberg, J. Bartunek, H. Jin, R. Yang, N.F. Paoni and B.H. Lorell, Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. Circulation, 99, 127–134 (1999).

    PubMed  CAS  Google Scholar 

  58. A. Cittadini, H. Stromer, D.E. Vatner, J.D. Grossman, S.E. Katz, R. Clark, J.P. Morgan and P.S. Douglas, Consequences of growth hormone deficiency on cardiac structure, function, and beta-adrenergic pathway: studies in mutant dwarf rats. Endocrinology, 138, 5161–5169 (1997).

    Article  PubMed  CAS  Google Scholar 

  59. H. Stromer, A. Cittadini, J.D. Grossma, P.S. Douglas and J.P. Morgan, Intrinsic cardiac muscle function, calcium handling and beta-adrenergic responsiveness is impaired in rats with growth hormone deficiency. Growth Horm IGF Res, 9, 262–271 (1999).

    Article  PubMed  CAS  Google Scholar 

  60. J. Ren and H. Brown-Borg, Impaired cardiac excitation-contraction coupling in ventricular myocytes from Ames dwarf mice with IGF-I deficiency. Growth Horm IGF Res; 12:99–105 (2002).

    Article  PubMed  CAS  Google Scholar 

  61. S. Kinugawa, H. Tsutsui, T. Ide, R. Nakamura, K. Arimura, K. Egashira and A. Takeshita, Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. Cardiovasc Res, 43, 157–164 (1999).

    Article  PubMed  CAS  Google Scholar 

  62. M.L. Solem, A.P. Thomas, Modulation of cardiac Ca2+ channels by IGF1. Biochem BiophysRes Commun, 252, 151–155 (1998).

    Article  CAS  Google Scholar 

  63. X.P. Xu and P.M. Best, Decreased transient outward K+current in ventricular myocytes from acromegalic rats. Am J Physiol 1991;260:H935–942

    PubMed  CAS  Google Scholar 

  64. H. Jin, R. Yang, H. Lu, A.K. Ogasawara, W. Li, A. Ryan, F. Peale and N.F. Paoni, Effects of early treatment with growth hormone on infarct size, survival, and cardiac gene expression after acute myocardial infarction. Growth Horm IGF Res, 12, 208–215 (2002).

    Article  PubMed  CAS  Google Scholar 

  65. T. Ueyama, T. Ohkusa, M. Yano and M. Matsuzaki, Growth hormone preserves cardiac sarcoplasmic reticulum Ca2+ release channels (ryanodine receptors) and enhances cardiac function in cardiomyopathic hamsters. Cardiovasc Res, 40, 64–73 (1998).

    Article  PubMed  CAS  Google Scholar 

  66. T.J. Caperna and D. Gavelek, Influences of somatotropin on Na+/K+-ATPase, Mg(2+)-ATPase and Ca(2+)-ATPases of Porcine visceral tissues. Comp Biochem Physiol B Biochem Mol Biol, 115, 13–18 (1996).

    Article  PubMed  CAS  Google Scholar 

  67. E. Mayoux, R. Ventura-Clapier, J. Timsit, F. Behar-Cohen, C. Hoffmann and J.J. Mercadier, Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion. Circ Res, 72, 57–64 (1993).

    PubMed  CAS  Google Scholar 

  68. J. Ren, Short-term administration of insulin-like growth factor I (IGF-1) does not induce myocardial IGF-1 resistance. Growth Horm IGF Res, 12, 162–168 (2002).

    Article  PubMed  CAS  Google Scholar 

  69. J. Timsit, B. Riou, J. Bertherat, C. Wisnewsky, N.S. Kato, A.S. Weisberg, J. Lubetzki, Y. Lecarpentier, S. Winegrad and J.J. Mercadier, Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest, 86, 507–515 (1990).

    Article  PubMed  CAS  Google Scholar 

  70. S. Longobardi, A. Cittadini, H. Stromer, S.E. Katz, J.D. Grossman, R.G. Clark, J.P. Morgan and P.S. Douglas, Echocardiographic assessment of cardiac morphology and function in mutant dwarf rats. Growth Horm IGF Res, 10, 242–247 (2000).

    Article  PubMed  CAS  Google Scholar 

  71. A. Cittadini, A. Cuocolo, B. Merola, S. Fazio, D. Sabatini, E. Nicolai, A. Colao, S. Longobardi, G. Lombardi and L. Sacca, Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am J Physiol, 267, E219–225 (1994).

    PubMed  CAS  Google Scholar 

  72. K. Caidahl, S. Eden and B.A. Bengtsson, Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf), 40, 393–400 (1994).

    CAS  Google Scholar 

  73. L. Brown, B. Wyse and C. Sernia, Adrenoceptor-mediated cardiac and vascular responses in genetically growth hormone-deficient rats. Biochem Pharmacol, 45, 2223–2229 (1993).

    Article  PubMed  CAS  Google Scholar 

  74. G. Amato, C. Carella, S. Fazio, G. La Montagna, A. Cittadini, D. Sabatini, C. Marciano-Mone, L. Sacca and A. Bellastella, Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab, 77, 1671–1676 (1993).

    Article  PubMed  CAS  Google Scholar 

  75. S. Fazio, A. Cittadini, D. Sabatini, B. Merola, A. Colao, B. Biondi, S. Longobardi, G. Lombardi and L. Sacca, Growth hormone and heart performance. A novel mechanism of cardiac wall stress regulation in humans. Eur Heart J, 18, 340–347 (1997).

    PubMed  CAS  Google Scholar 

  76. T. Rosen and B.A. Bengtsson, Premature mortality due to cardiovascular disease in hypopituitarism. Lancet; 336:285–288 (1990).

    Article  PubMed  CAS  Google Scholar 

  77. T. Rosen, S. Eden, G. Larson, L. Wilhelmsen and B.A. Bengtsson, Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh), 129, 195–200 (1993).

    CAS  Google Scholar 

  78. J.A. Barreto-Filho, M.R. Alcantara, R. Salvatori, M.A. Barreto, A.C. Sousa, V. Bastos, A.H. Souza, R.M. Pereira, P.E. Clayton, M.S. Gill and M.H. Aguiar-Oliveira, Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia. J Clin Endocrinol Metab, 87, 2018–2023 (2002).

    Article  PubMed  CAS  Google Scholar 

  79. D.G. Penney, J.C. Dunbar, Jr. and M.S. Baylerian, Cardiomegaly and haemodynamics in rats with a transplantable growth hormone-secreting tumour. Cardiovasc Res, 19, 270–277 (1985).

    Article  PubMed  CAS  Google Scholar 

  80. M.C. Delaughter, G.E. Taffet, M.L. Fiorotto, M.L. Entman and R.J. Schwartz, Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice. Faseb J, 13, 1923–1929 (1999).

    PubMed  CAS  Google Scholar 

  81. E. Bollano, E. Omerovic, M. Bohlooly-y, V. Kujacic, B. Madhu, J. Tornell, O. Isaksson, B. Soussi, W. Schulze, M.L. Fu, G. Matejka, F. Waagstein and J. Isgaard, Impairment of cardiac function and rjioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene. Endocrinology, 141, 2229–2235 (2000).

    Article  PubMed  CAS  Google Scholar 

  82. E Omerovic, M Basetti, E Bollano, M Bohlooly, J Tornell, J Isgaard, A Hjalmarson, B Soussi and F. Waagstein, In vivo metabolic imaging of cardiac bioenergetics in transgenic mice. Biochem Biophys Res Commun, 271, 222–228 (2000).

    Article  PubMed  CAS  Google Scholar 

  83. M. Losa and K. von Werder, The heart in acromegaly. In: F. Manelli, ed. Growth hormone and the heart. Kluwer Academic Publishers, Boston, pp 33–43 (2001).

    Google Scholar 

  84. Y.M. Bohlooly, L. Carlson, B. Olsson, H. Gustafsson, I.J. Andersson, J. Tornell and G. Bergstrom. Vascular function and blood pressure in GH transgenic mice. Endocrinology, 142, 3317–3323 (2001).

    Article  Google Scholar 

  85. M.L. Jaffrain-Rea, C. Moroni, R. Baldelli, C. Battista, P. Maffei, M. Terzolo, M. Correra, M.R. Ghiggi, E. Ferretti, A. Angeli, N. Sicolo, V. Trischitta, A. Liuzzi, R. Cassone and G. Tamburrano 2001 Relationship between blood pressure and glucose tolerance in acromegaly. Clin Endocrinol (Oxf), 54, 189–195 (2001).

    Article  CAS  Google Scholar 

  86. E.A. Palmieri, G. Benincasa, F. Di Rella, C. Casaburi, M.G. Monti, G. De Simone, L. Chiariotti, L. Palombini, C.B. Bruni, L. Sacca and A. Cittadini, Differential expression of TNF-alpha, IL-6, and IGF-1 by graded mechanical stress in normal rat myocardium. Am J Physiol Heart Circ Physiol, 282, H926–934 (2002).

    PubMed  CAS  Google Scholar 

  87. P.R. Standley, T.J. Obards and C.L. Martina, Cyclic stretch regulates autocrine IGF-I in vascular smooth muscle cells: implications in vascular hyperplasia. Am J Physiol, 276, E697–705 (1999).

    PubMed  CAS  Google Scholar 

  88. H. Wahlander, J. Isgaard, E. Jennische and P. Friberg, Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension, 19, 25–32 (1992).

    PubMed  CAS  Google Scholar 

  89. G. Guron, P. Friberg, A. Wickman, C. Brantsing, B. Gabrielsson and J. Isgaard, Cardiac insulin-like growth factor I and growth hormone receptor expression in renal hypertension. Hypertension, 27, 636–642 (1996).

    PubMed  CAS  Google Scholar 

  90. R. Ebensperger, E. Acevedo, J. Melendez, R. Corbalan, M. Acevedo, M. Sapag-Hagar, J.E. Mil and S. Lavandero, Selective increase in cardiac IGF-1 in a rat model of ventricular hypertrophy. Biochem Biophys Res Commun, 243, 20–24 (1998).

    Article  PubMed  CAS  Google Scholar 

  91. G. Andronico, M.T. Mangano, E. Nardi, G. Mule, G. Piazza and G. Cerasola, Insulin-like growth factor 1 and sodium-lithium countertransport in essential hypertension and in hypertensive left ventricular hypertrophy. J Hypertens, 11, 1097–1101 (1993).

    PubMed  CAS  Google Scholar 

  92. M. Galderisi, G. Vitale, G. Lupoli, M. Barbieri, G. Varricchio, C. Carella, O. de Divitiis, G. Paolisso Inverse association between free insulin-like growth factor-1 and isovolumic relaxation in arterial systemic hypertension. Hypertension, 38, 840–845 (2001).

    PubMed  CAS  Google Scholar 

  93. P. Verdecchia, G. Reboldi, G. Schillaci, C. Borgioni, A. Ciucci, M.P. Telera, F. Santeusanio, C. Porcellati and P. Brunetti, Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation; 100:1802–1807 (1999).

    PubMed  CAS  Google Scholar 

  94. C. Lemne and K. Brismar, Insulin-like growth factor binding protein-1 as a marker of the metabolic syndrome-a study in borderline hypertension. Blood Press, 7, 89–95 (1998).

    PubMed  CAS  Google Scholar 

  95. E. Dall’Aglio, I. Salimbeni, A. Rocci, S. Mazzoni, F. Corradi, E. Cattadori, S. Visioli, A. Banchini, G. Valenti and G.P. Ceda, Modifications of blood pressure and IGF-I levels after weight loss in obesity. J Endocrinol Invest, 25, 107–109 (2002).

    Google Scholar 

  96. L. Friberg, S. Werner, G. Eggertsen and S. Ahnve, Growth hormone and insulin-like growth factor-1 in acute myocardial infarction. Eur Heart J, 21, 1547–1554 (2000).

    Article  PubMed  CAS  Google Scholar 

  97. W.L. Lee, J.W. Chen, C.T. Ting, S.J. Lin and P.H. Wang, Changes of the insulin-like growth factor I system during acute myocardial infarction: implications on left ventricular remodeling. J Clin Endocrinol Metab, 84, 1575–1581 (1999).

    Article  PubMed  CAS  Google Scholar 

  98. A. Juul, T. Scheike, M. Davidsen, J. Gyllenborg and T. Jorgensen, Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation, 106, 939–944 (2002).

    Article  PubMed  CAS  Google Scholar 

  99. N. Vaessen, P. Heutink, J.A. Janssen, J.C. Witteman, L. Testers, A. Hofman, S.W. Lamberts, B.A. Oostra, H.A. Pols and C.M. van Duijn, A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes, 50, 637–642 (2001).

    PubMed  CAS  Google Scholar 

  100. R.V. Krishnamurthi, L. Maxwell, N.S. Bassett, J.B. Gavin, P.D. G and B.M. Johnston, The spatial and temporal distribution of insulin-like growth factor-1 following experimental myocardial infarction in the rat. Cardiovasc Pathol, 6, 197–203 (1997).

    Article  CAS  Google Scholar 

  101. R. Yang, S. Bunting, N. Gillett, R. Clark and H. Jin, Growth hormone improves cardiac performance in experimental heart failure. Circulation, 92, 262–267 (1995).

    PubMed  CAS  Google Scholar 

  102. J. Isgaard, V. Kujacic, E. Jennische, A. Holmäng, X.Y. Sun, T. Hedner, Å. Hjalmarson and B-Å. Bengtsson, Growth hormone improves cardiac function in rats with experimental myocardial infarction. Eur J Clin Invest, 27, 517–525 (1997).

    Article  PubMed  CAS  Google Scholar 

  103. H. Jin, R. Yang, N. Gillett, R.G. Clark, A. Ko and N.F. Paoni, Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition. J Cardiovasc Pharm, 26, 420–425 (1995).

    CAS  Google Scholar 

  104. E. Omerovic, R. Fahrami, M. Basetti, B. Soussi, Å. Hjalmarson, F. Waagstein and J. Isgaard, Growth hormone improves bioenergetics and decreases catecholamines in postinfarct rat hearts. Endocrinology, 141, 4592–4599 (2000).

    Article  PubMed  CAS  Google Scholar 

  105. A. Cittadini, J. Isgaard, M.G. Monti, C. Casaburi, A.D. Di Gianni, R. Serpico and R. Saccá, Growth hormone prolongs survival and attenuates interstitial remodeling in postinfarction heart failure. J Am Coll Cardiol, 41, 2154–2163 (2003).

    Article  PubMed  CAS  Google Scholar 

  106. M. Volterrani, P. Desenzani, R. Lorusso, A. d’Aloia, F. Manelli and A. Giustina, Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet, 349, 1067–1068 (1997).

    Article  PubMed  CAS  Google Scholar 

  107. S. Fazio, D. Sabatini, B. Capaldo, C. Vigorito, A. Giordano, R. Guida, F. Pardo, B. Biondi and L. Sacca, A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N EnglJ Med, 334, 809–814 (1996).

    Article  CAS  Google Scholar 

  108. K.J. Osterziel, O. Strohm, J. Schuler, M. Friedrich, D. Hanlein, R. Willenbrock, S.D. Anker, P.A. Poole-Wilson, M.B. Ranke and R. Dietz, Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet, 351, 1233–1237 (1998).

    Article  PubMed  CAS  Google Scholar 

  109. J. Isgaard, C.H. Bergh, K. Caidahl, M. Lomsky, A. Hjalmarson and B.A. Bengtsson, A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur Heart J, 19, 1704–1711 (1998).

    Article  PubMed  CAS  Google Scholar 

  110. S.D. Anker, M. Volterrani, C.D. Pflaum, C.J. Strasburger, K.J. Osterziel, W. Doehner, M.B. Ranke, P.A. Poole-Wilson, A. Giustina, R. Dietz and A.J. Coats, Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol, 38, 443–452 (2001).

    Article  PubMed  CAS  Google Scholar 

  111. T. Saaresranta and O. Polo, Hormones and breathing. Chest, 122, 2165–82 (2002).

    Article  PubMed  CAS  Google Scholar 

  112. B.G. Cooper, J.E. White, L.A. Ashworth, K.G. Alberti and G.J. Gibson, Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep, 18, 172–183 (1995).

    PubMed  CAS  Google Scholar 

  113. T.W. Felbinger, U. Suchner, A.E. Goetz, J. Briegel and K. Peter, Recombinant human growth hormone for reconditioning of respiratory muscle after lung volume reduction surgery. Crit Care Med, 27, 1634–1638 (1999).

    Article  PubMed  CAS  Google Scholar 

  114. G.S. Pape, M. Friedman, L.E. Underwood and D.R. Clemmons, The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest, 99, 1495–1500 (1991).

    PubMed  CAS  Google Scholar 

  115. R. Arens, D. Gozal, K.J. Omlin, J. Vega, K.P. Boyd, T.G. Keens and M.S. Woo, Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis. Am J Respir Crit Care Med, 150, 1154–1157 (1994).

    PubMed  CAS  Google Scholar 

  116. A.C. Lindgren, L.G. Hellstrom, E.M. Ritzen and J. Milerad, Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur J Pediatr, 158, 936–940 (1999).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center for Endocrinology and Metabolism, Department of Internal Medicine, Sahlgrenska Academy at the University of Göteborg, Göteborg, Sweden

    Åsa Tivesten & Jörgan Isgaard

Authors
  1. Åsa Tivesten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jörgan Isgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Instituto de Investigaciones Biomedicas “Alberto Sols” Consejo Superior de Investigaciones Cientificas (IIB-CSIC), Universidad Autonoma de Madrid (UAM), Arturo Duperier 4, 28029, Madrid, Spain

    Isabel Varela-Nieto PhD

  2. Department of Endocrinology and Investigation, Hospital Infantil Universitario Niño Jesús, Menéndez Pelayo, 65, 28009, Madrid, Spain

    Julie A. Chowen PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Tivesten, Å., Isgaard, J. (2005). Cardiovascular and Respiratory Systems. In: Varela-Nieto, I., Chowen, J.A. (eds) The Growth Hormone/Insulin-Like Growth Factor Axis During Development. Advances in Experimental Medicine and Biology, vol 567. Springer, Boston, MA. https://doi.org/10.1007/0-387-26274-1_6

Download citation

  • DOI: https://doi.org/10.1007/0-387-26274-1_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-25119-6

  • Online ISBN: 978-0-387-26274-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation